Stay updated on KarXT for Alzheimer's Psychosis: ADEPT-2 Clinical Trial
Sign up to get notified when there's something new on the KarXT for Alzheimer's Psychosis: ADEPT-2 Clinical Trial page.

Latest updates to the KarXT for Alzheimer's Psychosis: ADEPT-2 Clinical Trial page
- Check3 days agoChange DetectedRevision: v3.6.4 is now shown, replacing the previous v3.6.3 tag to reflect an updated version of the page.SummaryDifference0.0%

- Check10 days agoChange DetectedDifference0.2%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedPage revision updated from v3.6.2 to v3.6.3, indicating a minor revision to the study record. The change updates the metadata or formatting without altering the study data.SummaryDifference0.0%

- Check32 days agoChange DetectedThe page's revision tag was updated from v3.6.0 to v3.6.2, indicating a minor update to the page's underlying system. No visible changes to study content or layout are expected.SummaryDifference0.0%

- Check39 days agoChange DetectedThe study record received updates indicating new status information and dates, including a new 'Completed' marker, and the previous 'Active, not recruiting' designation was removed, signaling a progression in the trial's status.SummaryDifference0.1%

- Check46 days agoChange DetectedNew quick-access links were added on the study details page, including 'Check who can join', 'Find Contact Information', 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study', and the version label was updated from v3.5.5 to v3.6.0 with a formatting change from 'Intervention / Treatment' to 'Intervention/Treatment'.SummaryDifference0.2%

Stay in the know with updates to KarXT for Alzheimer's Psychosis: ADEPT-2 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KarXT for Alzheimer's Psychosis: ADEPT-2 Clinical Trial page.